Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epicardial Adipose Tissue from Computed Tomography: a Missing Link in Premature Coronary Artery Disease?
Ritvo PG, Charpentier E, Zeitouni M, Rahoual G, Boussouar S, Croisille C, Silvain J, Kerneis M, Procopi N, Rouanet S, Kachenoura N, Montalescot G, Redheuil A. Ritvo PG, et al. Among authors: kerneis m. Eur Heart J Cardiovasc Imaging. 2025 Jan 7:jeae335. doi: 10.1093/ehjci/jeae335. Online ahead of print. Eur Heart J Cardiovasc Imaging. 2025. PMID: 39764675
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event.
Silvain J, Materne C, Zeitouni M, Procopi N, Guedeney P, Brugier D, Galier S, Lhomme M, Ponnaiah M, Guillas I, Kc P, Dahik VD, Frisdal E, Vicaut E, Lesnik P, Rahoual G, Le Goff W, Montalescot G, Kerneis M, Guerin M. Silvain J, et al. Among authors: kerneis m. Eur J Prev Cardiol. 2024 Nov 7:zwae356. doi: 10.1093/eurjpc/zwae356. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 39506545
Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning.
Zeitouni M, Dorvillius E, Sulman D, Procopi N, Beaupré F, Devos P, Barthélémy O, Rouanet S, Ferrante A, Chommeloux J, Hekimian G, Kerneis M, Silvain J, Montalescot G; ACTION Study Group. Zeitouni M, et al. Among authors: kerneis m. Am J Cardiovasc Drugs. 2024 Oct 21. doi: 10.1007/s40256-024-00683-z. Online ahead of print. Am J Cardiovasc Drugs. 2024. PMID: 39432228
Beta-Blocker Interruption or Continuation after Myocardial Infarction.
Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, Guedeney P, Cuisset T, Ivanes F, Lhermusier T, Petroni T, Lemesle G, Bresoles F, Labeque JN, Pommier T, Dillinger JG, Leclercq F, Boccara F, Lim P, Besseyre des Horts T, Fourme T, Jourda F, Furber A, Lattuca B, Redjimi N, Thuaire C, Deharo P, Procopi N, Dumaine R, Slama M, Payot L, El Kasty M, Aacha K, Diallo A, Vicaut E, Montalescot G; ABYSS Investigators of the ACTION Study Group. Silvain J, et al. N Engl J Med. 2024 Oct 10;391(14):1277-1286. doi: 10.1056/NEJMoa2404204. Epub 2024 Aug 30. N Engl J Med. 2024. PMID: 39213187 Clinical Trial.
Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women.
Weizman O, Hauguel-Moreau M, Tea V, Albert F, Barragan P, Georges JL, Delarche N, Kerneis M, Bataille V, Drouet E, Puymirat E, Ferrières J, Schiele F, Simon T, Danchin N; FAST-MI Investigators. Weizman O, et al. Among authors: kerneis m. Eur J Prev Cardiol. 2024 Nov 11;31(15):1850-1860. doi: 10.1093/eurjpc/zwae255. Eur J Prev Cardiol. 2024. PMID: 39192488
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort.
Sulman D, Beaupré F, Devos P, Procopi N, Kerneis M, Guedeney P, Barthélémy O, Elhadad A, Rouanet S, Brugier D, Hekimian G, Chommeloux J, Combes A, Silvain J, Collet JP, Montalescot G, Zeitouni M; ACTION group. Sulman D, et al. Among authors: kerneis m. Arch Cardiovasc Dis. 2024 Oct;117(10):569-576. doi: 10.1016/j.acvd.2024.07.059. Epub 2024 Aug 6. Arch Cardiovasc Dis. 2024. PMID: 39153876
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial.
McNamara DM, Cooper LT, Arbel Y, Bhimaraj A, Bocchi E, Friedrich MG, Kerneis M, Liu P, Parker AB, Smith ER, Tang WHW, Torre-Amione G, Tschöpe C; ARCHER Study Group. McNamara DM, et al. Among authors: kerneis m. ESC Heart Fail. 2024 Oct;11(5):3416-3424. doi: 10.1002/ehf2.14889. Epub 2024 Jun 27. ESC Heart Fail. 2024. PMID: 38937900 Free PMC article. Clinical Trial.
Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome.
Manzo-Silberman S, Guedeney P, Cayla G, Beygui F, Rangé G, Motovska Z, Procopi N, Kerneis M, Zeitouni M, El Kasty M, Teiger E, Filippi E, Coste P, Huchet F, Cottin Y, Karasek J, Arnould MA, Braik N, Barthelemy O, Portal JJ, Vicaut E, Montalescot G, Silvain J; ALPHEUS Investigators. Manzo-Silberman S, et al. Among authors: kerneis m. JACC Cardiovasc Interv. 2024 Jun 24;17(12):1413-1421. doi: 10.1016/j.jcin.2024.04.015. Epub 2024 Jun 5. JACC Cardiovasc Interv. 2024. PMID: 38842993 Clinical Trial.
146 results